Evidence map›Paper›PMID 39921890›Full record

ArticleBioinformatics (Oxford, England)2025

NMFProfiler: a multi-omics integration method for samples stratified in groups.

Aurélie Mercadié, Éléonore Gravier, Gwendal Josse, Isabelle Fournier, Cécile Viodé, Nathalie Vialaneix, Céline Brouard

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aurélie MercadiéRecherche & Développement, Pierre Fabre Dermo-cosmétique, Toulouse 31300, France.ORCID 0009-0000-3440-0596
Éléonore GravierRecherche & Développement, Pierre Fabre Dermo-cosmétique, Toulouse 31300, France.
Gwendal JosseRecherche & Développement, Pierre Fabre Dermo-cosmétique, Toulouse 31300, France.ORCID 0000-0003-3375-5226
Isabelle FournierUniversité de Lille, Inserm, CHU Lille, U1192 PRISM, Lille 59000, France.ORCID 0000-0003-1096-5044
Cécile ViodéRecherche & Développement, Pierre Fabre Dermo-cosmétique, Toulouse 31300, France.
Nathalie VialaneixUniversité de Toulouse, INRAE, UR MIAT, Castanet-Tolosan Cedex 31326, France.ORCID 0000-0003-1156-0639
Céline BrouardUniversité de Toulouse, INRAE, UR MIAT, Castanet-Tolosan Cedex 31326, France.ORCID 0000-0002-5574-7027

Funding

Agence Nationale de la Recherche et de la Technologie 2022/0051
6 · The paper itself

Abstract

motivationThe development of high-throughput sequencing enabled the massive production of "omics" data for various applications in biology. By analyzing simultaneously paired datasets collected on the same samples, integrative statistical approaches allow researchers to get a global picture of such systems and to highlight existing relationships between various molecular types and levels. Here, we introduce NMFProfiler, an integrative supervised NMF that accounts for the stratification of samples into groups of biological interest.

resultsNMFProfiler was shown to successfully extract signatures characterizing groups with performances comparable to or better than state-of-the-art approaches. In particular, NMFProfiler was used in a clinical study on atopic dermatitis (AD) and to analyze a multi-omic cancer dataset. In the first case, it successfully identified signatures combining known AD protein biomarkers and novel transcriptomic biomarkers. In addition, it was also able to extract signatures significantly associated to cancer survival. AVAILABILITY AND IMPLEMENTATION: NMFProfiler is released as a Python package, NMFProfiler (v0.3.0), available on PyPI.

Indexed as

Computational BiologyGenomicsSoftwareDermatitis, AtopicGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansMultiomicsNeoplasmsTranscriptome

Identifiers

PMID39921890
PMCPMC11855281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.